| Phase 22 trials |
|
Phase 2
|
NCT06967428 |
Sep 2025 → Jan 2026 overdue |
— |
Independent Medical Alliance |
Not yet recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT03580616 |
Oct 2018 → Aug 2022 |
amyotrophic lateral sclerosis |
Elijah W. Stommel |
Terminated
|
No outcome recorded
|
| Phase 31 trial |
|
Phase 3
|
NCT07342439 |
Sep 2026 → Nov 2029 expected |
macular telangiectasia type 2 |
The Lowy Medical Research Institute Limited |
Not yet recruiting
|
No outcome recorded
|
| Comparator or background therapy4 trials |
|
Phase 1/2
|
NCT01733407 Comparator |
Sep 2013 → May 2016 |
hereditary sensory and autonomic neuropathy type 1 |
Massachusetts General Hospital |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT01835782 Comparator |
Jan 2013 → Dec 2016 |
amyotrophic lateral sclerosis |
Phoenix Neurological Associates, LTD |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT06113055 Comparator |
Aug 2023 → Aug 2025 |
hereditary sensory and autonomic neuropathy type 1 |
University College, London |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT03062449 Comparator |
Mar 2017 → Jul 2021 |
Alzheimer disease |
Aleksandra Stark |
Terminated
|
No outcome recorded
|